Investigators used peripheral blood and bone marrow samples from patients with acute myeloid leukemia (AML) to analyze the impact of CD157-directed antibodies in AML survival and in response to cytarabine ex vivo.
[Scientific Reports]
7992332
{7992332:BBBBBBBB}
apa
50
1
168488
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
